Alexandra Balcom

Affiliations

  • Director at Glycomimetics Inc (CBIO), 2025-06-23
  • Chief Financial Officer at Nuvalent Inc. (NUVL), 2025-01-08
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
NUVL $80.54 2,173 $175,013.42 61,734 2025-01-06 Filing
NUVL $79.33 691 $54,817.03 63,907 2025-01-06 Filing
NUVL $78.28 1,152 $90,178.56 64,598 2025-01-06 Filing
NUVL $96.25 1,858 $178,832.50 33,300 2024-11-29 Filing
NUVL $95.69 8,142 $779,107.98 35,158 2024-11-29 Filing